Orchard Therapeutics - U.S.

Therapeutic Operations Lead - Benelux

Orchard Therapeutics - U.S.  •  Amsterdam, NL (Remote)  •  1 month ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Location: Field-Based, Netherlands

Reporting to: General Manager, Nordic & Benelux

Orchard Therapeutics, a Kyowa Kirin company, is a global gene therapy leader focused on transforming the lives of patients with rare disorders through innovative gene therapies based on gene-modified hematopoietic stem cells (HSCs). Orchard has its global headquarters in London, England, and its U.S. headquarters in Boston, Massachusetts.

Reporting to the General Manager, Nordic & Benelux, the Therapeutic Operations Lead will be responsible for delivering the company’s commercial business in neurometabolic disorders. This will include building trusted relationships with qualified treatment centers, healthcare professionals and patient organizations with the aim of promoting early identification and access to treatment of eligible patients in Benelux and to identify new opportunities to grow the company’s pipeline.

This is a unique opportunity to contribute to the rapid growth and success of a leading biotechnology company with a transformative technology.

Key elements and responsibilities, including but not limited to:

· Develop trusted relationships with qualified treatment centers (QTC’s), healthcare professionals and patient organizations

· Supporting the QTC in Utrecht, The Netherland and coordinating patient’s treatment ensuring that it adheres to what is described in the Product Manual and facilitating the exchange of the related mandatory documentation with Orchard’s Supply Chain Team

· In partnership with the Medical Director, engage disease experts via advisory boards and individual interactions to accelerate patient identification and diagnosis

· Oversee the development of disease-related and product-related materials and their approval for use in the Benelux, in partnership with the Medical Director

· Drive disease awareness and the identification of potential patient candidates for treatment with Libmeldy® and other Orchard gene therapies

· Resolve issues of access to treatment by potential patient candidates to gene therapy, in collaboration with the Market Access function

· Plan activities and track budget in the franchise

· Role-model corporate values and behaviours; foster compliance with legal and regulatory requirements and corporate SOPs, and the pursuit of the highest ethical standards

· Performs other tasks and assignments as needed and specified by management. regarding the strategy and operations in the neurometabolic franchise

· Represent Orchard during meetings and congresses.

Requirements

Education / Key Competencies

· Resident in the Netherlands

· Experience of working in the Benelux region preferred

· Minimum 5+ years of experience in pharmaceutical and/or biotech industry. 2+ years in rare disease and/or gene therapy preferred

· First rate academic background; undergraduate degree in pharmaceutical, medical or scientific discipline

· MD, PhD and or relevant post-graduate business degree is preferred

· Considerable experience in the commercial or medical affairs functions of pharmaceutical companies with proven expertise supporting product launches, innovative therapies and medical-marketing projects

· Experience working in rare disease or specialty disease

· A track record of building trusted relationships with disease experts (in partnership with the medical team) and other public influencers, to drive adoption of a therapy

· A good scientific acumen

· A team mindset embracing cross-functional collaboration

· Entrepreneurial spirit, solution-oriented and an operational approach to the business

· An individual with high resilience who thrives on overcoming obstacles

· Excellent verbal and written communication in Dutch and English

· Excellent verbal and written communication in French would be beneficial

· Proficiency with the suite of Microsoft Office applications (Word, PowerPoint, Excel)

· Ability to travel extensively (up to 50% of time)

Orchard is an equal opportunity employer. We recognise and celebrate the diverse culture of our workforce and are committed to creating an inclusive environment for our employees. We fully support the principle of Equality and Diversity in employment and oppose all forms of unlawful or unfair discrimination. We assess all applications on basis of job requirements and individual qualifications.

We work within the requirements of all current legislation and we implement the provisions of regulatory codes of practice in employment.

Notice to All Applicants: Orchard Therapeutics participates in E-Verify

RECRUITERS

All employment offers and CV’s are managed through our Human Resources Department and all candidates are presented through this avenue. Therefore, the Human Resources Department at Orchard Therapeutics requests that recruiters are not to contact Orchard Therapeutics employees directly to present candidates. Complying with this request will be a factor in determining future professional relationships with Orchard Therapeutics. Orchard Therapeutics will not accept unsolicited resumes from any source other than directly from candidates for either current or future positions. Submission of unsolicited resumes in advance of an agreement between the Human Resources Department and the recruiter does not create any implied obligation on the part of Orchard Therapeutics.

Orchard Therapeutics - U.S.

About Orchard Therapeutics - U.S.

Orchard Therapeutics, a Kyowa Kirin company, is a global gene therapy leader focused on ending the devastation caused by genetic and other severe diseases by discovering, developing, and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease with a single treatment.

Founded in 2015, Orchard’s roots go back to some of the first research and clinical developments involving HSC gene therapy. Our team has played a central role in the evolution of this technology from a promising scientific idea to a potentially life-transforming reality. Today, Orchard is advancing a pipeline of HSC gene therapies designed to address serious diseases where the burden is immense for patients, families and society and current treatment options are limited or do not exist.

For more information, please visit https://www.orchard-tx.com/.

Industry
Unknown
Company Size
201-500 employees
Headquarters
London, GB
Year Founded
2015
Social Media